Taiwan · Delayed Price · Currency is TWD Puriblood Medical Statistics
Total Valuation
TPEX:6847 has a market cap or net worth of TWD 1.26 billion. The enterprise value is 1.25 billion.
| Market Cap | 1.26B |
| Enterprise Value | 1.25B |
Important Dates
The next estimated earnings date is Friday, August 14, 2026.
| Earnings Date | Aug 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TPEX:6847 has 14.23 million shares outstanding. The number of shares has increased by 0.79% in one year.
| Current Share Class | 14.23M |
| Shares Outstanding | 14.23M |
| Shares Change (YoY) | +0.79% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 22.35% |
| Owned by Institutions (%) | 6.62% |
| Float | 6.42M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 15.33 |
| PB Ratio | 9.00 |
| P/TBV Ratio | 9.50 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -32.12 |
| EV / Sales | 15.22 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -44.95 |
Financial Position
The company has a current ratio of 2.12, with a Debt / Equity ratio of 0.36.
| Current Ratio | 2.12 |
| Quick Ratio | 1.56 |
| Debt / Equity | 0.36 |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.83 |
| Interest Coverage | -31.13 |
Financial Efficiency
Return on equity (ROE) is -24.72% and return on invested capital (ROIC) is -25.56%.
| Return on Equity (ROE) | -24.72% |
| Return on Assets (ROA) | -8.43% |
| Return on Invested Capital (ROIC) | -25.56% |
| Return on Capital Employed (ROCE) | -18.73% |
| Weighted Average Cost of Capital (WACC) | 4.78% |
| Revenue Per Employee | 1.87M |
| Profits Per Employee | -886,432 |
| Employee Count | 44 |
| Asset Turnover | 0.33 |
| Inventory Turnover | 1.61 |
Taxes
In the past 12 months, TPEX:6847 has paid 237,000 in taxes.
| Income Tax | 237,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +1.62% in the last 52 weeks. The beta is 0.12, so TPEX:6847's price volatility has been lower than the market average.
| Beta (5Y) | 0.12 |
| 52-Week Price Change | +1.62% |
| 50-Day Moving Average | 62.56 |
| 200-Day Moving Average | 70.70 |
| Relative Strength Index (RSI) | 79.29 |
| Average Volume (20 Days) | 41,112 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:6847 had revenue of TWD 82.34 million and -39.00 million in losses. Loss per share was -2.74.
| Revenue | 82.34M |
| Gross Profit | 32.31M |
| Operating Income | -33.44M |
| Pretax Income | -38.77M |
| Net Income | -39.00M |
| EBITDA | -27.14M |
| EBIT | -33.44M |
| Loss Per Share | -2.74 |
Balance Sheet
The company has 60.43 million in cash and 51.04 million in debt, with a net cash position of 9.39 million or 0.66 per share.
| Cash & Cash Equivalents | 60.43M |
| Total Debt | 51.04M |
| Net Cash | 9.39M |
| Net Cash Per Share | 0.66 |
| Equity (Book Value) | 140.21M |
| Book Value Per Share | 9.85 |
| Working Capital | 65.37M |
Cash Flow
In the last 12 months, operating cash flow was -27.39 million and capital expenditures -479,000, giving a free cash flow of -27.87 million.
| Operating Cash Flow | -27.39M |
| Capital Expenditures | -479,000 |
| Depreciation & Amortization | 7.80M |
| Net Borrowing | -803,000 |
| Free Cash Flow | -27.87M |
| FCF Per Share | -1.96 |
Margins
Gross margin is 39.24%, with operating and profit margins of -40.61% and -47.37%.
| Gross Margin | 39.24% |
| Operating Margin | -40.61% |
| Pretax Margin | -47.08% |
| Profit Margin | -47.37% |
| EBITDA Margin | -32.97% |
| EBIT Margin | -40.61% |
| FCF Margin | n/a |
Dividends & Yields
TPEX:6847 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.79% |
| Shareholder Yield | -0.79% |
| Earnings Yield | -3.09% |
| FCF Yield | -2.21% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TPEX:6847 has an Altman Z-Score of 7.24 and a Piotroski F-Score of 2.
| Altman Z-Score | 7.24 |
| Piotroski F-Score | 2 |